AccuRad
Latest round
- Series C
Last raised
- Dec 2016
Total raised
- Undisclosed
Investors
- 3
About AccuRad
Founded in 2012 and based in Xi’an, China, AccuRad operates as a medical imaging device development company that focuses on medical image processing, analysis, and related services based on the cloud computing iMAGES engine. It was recognized as the National High-tech Enterprise. Conghui Jiang, the general manager of the company, graduated from Zhejiang University and used to work as a programmer for Alibaba from 2002-2004. AccuRad mainly engages in the development of medical imaging solutions. It provides users with imaging data cloud services, clinical image collaboration, medical technology work and collaboration systems, medical consortiums, regional medical technology platforms, independent imaging center cloud platforms, and other products and services. The company has served more than 2,500 enterprise clients, including the Affiliated Hospital of Jiaxing University, Health 100, etc. The company generates revenue by providing medical imaging solutions.
Who invested in AccuRad
3 investors across 2 rounds
See all investors in AccuRad
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AccuRad
Who invested in AccuRad?
AccuRad has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AccuRad raised?
AccuRad has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AccuRad last raise money?
AccuRad's most recent round on record is a Series C, in Dec 2016.
What does AccuRad do?
Founded in 2012 and based in Xi’an, China, AccuRad operates as a medical imaging device development company that focuses on medical image processing, analysis, and related services based on the cloud computing iMAGES engine.
Where is AccuRad headquartered?
AccuRad is headquartered in Xi'an, China.
Which VCs invest in companies like AccuRad?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at AccuRad's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series C
Raising like AccuRad? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.